At the fifth WHO Pharmaceutical Pricing and Reimbursement Policies conference today, Doctors Without Borders/Médecins Sans Frontières (MSF) presented the costs of its landmark TB-PRACTECAL clinical trial that helped identify a shorter, all-oral treatment regimen for drug-resistant tuberculosis (DR-TB), * which totalled €34 million. * This is the first time the detailed costs of an individual […]
MSF reveals cost of its landmark TB clinical trial in precedent-setting move towards drug-development cost transparency
